TipRanks
Advertisement
Advertisement

PRRUF Stock Latest News

Immutep Details Equity Interests of Departing Director Pete Meyers
Company AnnouncementsImmutep Details Equity Interests of Departing Director Pete Meyers
8h ago
Immutep Reports Lapse of 2 Million Performance Rights
PremiumCompany Announcements
Immutep Reports Lapse of 2 Million Performance Rights
8h ago
Immutep Announces Board Resignation and Search for New Non-Executive Director
PremiumCompany Announcements
Immutep Announces Board Resignation and Search for New Non-Executive Director
9h ago
Immutep Director Increases Shareholding Through Performance Rights Exercise
PremiumCompany Announcements
Immutep Director Increases Shareholding Through Performance Rights Exercise
4d ago
Immutep Applies to Quote New Ordinary Shares on ASX
PremiumCompany Announcements
Immutep Applies to Quote New Ordinary Shares on ASX
4d ago
Immutep receives A$856,669 cash rebate from Australia R&D tax incentive program
PremiumThe FlyImmutep receives A$856,669 cash rebate from Australia R&D tax incentive program
5d ago
IMMP
Immutep boosts R&D funding with multi-jurisdiction tax incentives
Premium
Company Announcements
Immutep boosts R&D funding with multi-jurisdiction tax incentives
5d ago
Immutep Ltd trading halted, news pending
Premium
The Fly
Immutep Ltd trading halted, news pending
9d ago
IMMP
Immutep Adjusts ADS Ratio to Safeguard Nasdaq Listing
PremiumCompany Announcements
Immutep Adjusts ADS Ratio to Safeguard Nasdaq Listing
14d ago
Immutep provides update on development strategy for eftilagimod alfa
PremiumThe Fly
Immutep provides update on development strategy for eftilagimod alfa
24d ago
RDY
IMMP
Immutep Refocuses Efti Development After Manufacturing Probe
PremiumCompany Announcements
Immutep Refocuses Efti Development After Manufacturing Probe
24d ago
S&P Dow Jones Indices Unveils September Rebalance of Key S&P/ASX Benchmarks
PremiumCompany Announcements
S&P Dow Jones Indices Unveils September Rebalance of Key S&P/ASX Benchmarks
1M ago
Immutep Revenue Jumps on Dr Reddy’s Deal but Loss Widens on R&D Spend
PremiumCompany AnnouncementsImmutep Revenue Jumps on Dr Reddy’s Deal but Loss Widens on R&D Spend
1M ago
Immutep balances TACTI-004 setback with upbeat efti and IMP761 data
Premium
Company Announcements
Immutep balances TACTI-004 setback with upbeat efti and IMP761 data
2M ago
Immutep’s Sarcoma Quality-of-Life Data Accepted for ESMO 2026
Premium
Company Announcements
Immutep’s Sarcoma Quality-of-Life Data Accepted for ESMO 2026
2M ago
Immutep granted new patent for eftilagimod alfa combination
PremiumThe Fly
Immutep granted new patent for eftilagimod alfa combination
3M ago
IMMP
Immutep Wins Fourth U.S. Patent for Key Cancer Immunotherapy Combination
PremiumCompany Announcements
Immutep Wins Fourth U.S. Patent for Key Cancer Immunotherapy Combination
3M ago
Immutep Posts Strong NSCLC Survival Data as It Probes Phase III Setback
PremiumCompany Announcements
Immutep Posts Strong NSCLC Survival Data as It Probes Phase III Setback
3M ago
JPMorgan Group Ceases to Be Substantial Holder in Immutep
PremiumCompany Announcements
JPMorgan Group Ceases to Be Substantial Holder in Immutep
3M ago
Immutep upgraded to Buy from Hold at Maxim
PremiumThe FlyImmutep upgraded to Buy from Hold at Maxim
4M ago
IMMP
JPMorgan Chase Ceases to Be Substantial Holder in Immutep
Premium
Company Announcements
JPMorgan Chase Ceases to Be Substantial Holder in Immutep
4M ago
JPMorgan Ceases to Be Substantial Holder in Immutep Ltd
Premium
Company Announcements
JPMorgan Ceases to Be Substantial Holder in Immutep Ltd
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >